Anzeige
Mehr »
Login
Dienstag, 21.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Aktienchance des Jahres! Ihre Chance auf explosive Gewinne!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40SG8 | ISIN: US45784G2003 | Ticker-Symbol: EO30
Frankfurt
20.01.25
08:00 Uhr
1,920 Euro
0,000
0,00 %
Branche
Logistik/Transport
Aktienmarkt
ASIEN
1-Jahres-Chart
ZOOMCAR HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
ZOOMCAR HOLDINGS INC 5-Tage-Chart
PR Newswire
158 Leser
Artikel bewerten:
(1)

Zoomcar Launches 'Zoomcar Cabs': Affordable Car Rentals with Drivers as a New Offering

Finanznachrichten News

BENGALURU, India, Dec. 20, 2024 /PRNewswire/ -- Zoomcar Holdings, Inc. ("Zoomcar" or the "Company") (NASDAQ: ZCAR), India's leading car-sharing marketplace, has announced the launch of Zoomcar Cabs, as a pilot in Bengaluru, that provides commercial cars with professional drivers at the best prices. Expanding beyond its successful self-drive offerings, this expansion into chauffeur-driven services marks Zoomcar's commitment to diversifying its offerings and enhancing customer experiences.

Zoomcar Cabs stems from a clear need expressed by Guests for a reliable, transparent alternative to traditional cab services, as Guests often compare self-drive options with chauffeur-driven services. In the last 6 months, Zoomcar has significantly improved profitability and is now strategically investing in new product lines to meet growing demand and elevate the overall customer experience.

In the current cab market, options are often limited only to selecting a car category like sedan, hatchback, etc, leaving customers uncertain about the exact car model or the condition of the car they will receive. Zoomcar's AI technology in cataloging, pricing, and image enhancement ensures every inventory item is unique, so Guests have the benefit to select the exact car model, see reviews and ratings by other Guests, car quality and condition preferences like year make, age, boot space, etc. Additionally, Guests simply need to add their pick up or start location on the Zoomcar app and have full control of their stops, route, destination, etc without the need to update it on app. Zoomcar Cabs offers the freedom to book a car for as little as two hours to extended periods of over 30 days.

Hiroshi Nishijima, CEO, Zoomcar said, "The launch of Zoomcar Cabs reflects Zoomcar's focus on listening to customer feedback and delivering tailored solutions with an added layer of transparency and flexibility that sets it apart from other apps. Guests can effortlessly book their preferred vehicles, whether for self-drive or with a driver, all through the single Zoomcar app - eliminating the need for multiple apps to meet their travel needs."

These technological advancements position Zoomcar to offer a seamless, scalable service that sets a new standard in the cab industry. The Bengaluru pilot serves as a beta project to validate this model, with plans for expansion to other cities in 2025 based on its success. These unique features set Zoomcar Cabs apart from other cab services and apps, ensuring Guests experience a combination of diversity, quality, choice and freedom. Whether for business trips, family vacations, or everyday commutes, Zoomcar Cabs is designed to meet diverse use cases, ensuring comfort, reliability, and affordability.

About Zoomcar

Founded in 2013 and headquartered in Bengaluru, India, Zoomcar is a leading marketplace for car sharing focused in India. The Zoomcar community connects Hosts with Guests, who choose from a selection of cars for use at affordable prices, promoting sustainable, smart transportation solutions in India.

Forward-Looking Statement:

Except for any historical/factual information contained herein, this press release may contain forward-looking statements about our plans, efforts, goals, assumptions, commitments, expectations, or prospects inter alia related to Zoomcar's Cab services offering and reflect our management's expectations for the business. These forward looking statements entail significant risk and uncertainty. To identify these forward-looking statements, we use terms such as "may," "will," "aim," "enable," "increase," "estimate," "intend," "indicate," "continue," "expand," "enhance," "believe," "elevate", "supports,", "ensure", "drives," "expect" or the negatives thereof, as well as other variations or comparable terminology. We ask that you read statements that contain these terms carefully because we believe this information is important for our investors and customers. Any forward-looking statement in this press release refers solely to what is accurate as of the day it is issued or based on assumptions that Zoomcar believes to be reasonable. The actual results and outcomes may materially differ due to various factors or events beyond our control which may not be foreseeable at all times. We cannot guarantee or assure any plan, initiative, projection, goal, assumption, commitment, expectation, or prospects set forth in this press release can or will be achieved. We undertake no obligation to alter or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, save and except as required by law.

Press Contact:

  • Akarshit Gulati: [email protected]
  • Bhagyashree Rewatkar : [email protected]

Logo: https://mma.prnewswire.com/media/2517562/5014195/Zoomcar_Logo.jpg

SOURCE Zoomcar

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.